Skip to content

King Pharmaceuticals KG Short-Duration Insurance Contracts, Incurred Claims and Allocated Claim Adjustment Expense, Net

Short-Duration Insurance Contracts, Incurred Claims and Allocated Claim Adjustment Expense, Net at other companies

Axis Capital Holders logo
Axis Capital HoldersAXS
$8.27B+694%
Axis Capital Holders logo
Axis Capital HoldersAXS
$7.13B+638%
RLI logo
RLIRLI
110,834,300,000%+88,698,500,000pp
RLI logo
RLIRLI
9,905,200,000%+7,576,800,000pp
Global Indemnity Group, LLC
 logo
Global Indemnity Group, LLC GBLI
45,611,300,000%+33,799,000,000pp
RLI logo
RLIRLI
125,030,300,000%+102,455,600,000pp

Segments

By product

See full
Commercial Auto Liability118,410,600,000%+405%
General Liability111,127,700,000%+539%
European Hospital Liability72,703,300,000%+416%
International56,319,200,000%+549%
All other lines48,915,900,000%+374%

Other financials

Income statement

See full
Revenue$10.2M+1,112%
Net income-$7.4M-1,786%
EPS (diluted)-$0.96-586%

Balance sheet

See full
Cash & equivalents$62.2M+1,724%
Total debt$176.7M
Total equity$121.4M+2,773%
Total assets$964.2M

Cash flow

See full
Operating cash flow-$15.1M-1,628%

Valuation

See full
Market cap$70.42M-67.6%
Enterprise value$184.93M-50.0%
P/E1.2×
P/S1.6×-24.3×

Profitability

See full
Net margin131.5%

Returns & leverage

See full
Return on equity90.8%
Debt / equity1.5×